CoChat

Assessment of Tropism and Effectiveness of New Primate-Derived Hybrid Recombinant AAV Serotypes in the Mouse and Primate Retina

Open access
Charbel Issa, Peter, De Silva, Samantha R., Lipinski, Daniel M., Singh, Mandeep S., Mouravlev, Alexandre, You, Qisheng, Barnard, Alun R., Hankins, Mark W., During, Matthew J., MacLaren, Robert E. · 2013 · PLoS ONE

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

Adeno-associated viral vectors (AAV) have been shown to be safe in the treatment of retinal degenerations in clinical trials. Thus, improving the efficiency of viral gene delivery has become increasingly important to increase the success of clinical trials. In this study, structural domains of different rAAV serotypes isolated from primate brain were combined to create novel hybrid recombinant AAV serotypes, rAAV2/rec2 and rAAV2/rec3. The efficacy of these novel serotypes were assessed in wild type mice and in two models of retinal degeneration (the Abca4(-/-) mouse which is a model for Stargardt disease and in the Pde6b(rd1/rd1) mouse) in vivo, in primate tissue ex-vivo, and in the human-derived SH-SY5Y cell line, using an identical AAV2 expression cassette. We show that these novel hybrid serotypes can transduce retinal tissue in mice and primates efficiently, although no more than AAV2/2 and rAAV2/5 serotypes. Transduction efficiency appeared lower in the Abca4(-/-) mouse compared to wild type with all vectors tested, suggesting an effect of specific retinal diseases on the efficiency of gene delivery. Shuffling of AAV capsid domains may have clinical applications for patients who develop T-cell immune responses following AAV gene therapy, as specific peptide antigen sequences could be substituted using this technique prior to vector re-treatments.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0060361

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 (a) Analysis of in vivo measurement of fluorescence intensity 3 weeks after subretinal injection of different hybrid recombinant AAV serotypes expressing green fluorescent protein (mean±SEM). Besides wild type (WT) mice, a strain with totally degenerate retina (Pde6brd1/rd1 mouse) as well as a strain with strong lipofuscin accumulation in the retinal pigment epithelium (Abca4−/− mouse) were used. 4 to 8 eyes were analysed per group. (b) Representative topographical confocal scanning laser ophthalmoscopy (cSLO) 488 nm-fluorescence images showing the range of fluorescence intensities that was found in the different groups.
Figure 1 (a) Analysis of in vivo measurement of fluorescence intensity 3 weeks after subretinal injection of different hybrid recombinant AAV serotypes expressing green fluorescent protein (mean±SEM). Besides wild type (WT) mice, a strain with totally degenerate retina (Pde6brd1/rd1 mouse) as well as a strain with strong lipofuscin accumulation in the retinal pigment epithelium (Abca4−/− mouse) were used. 4 to 8 eyes were analysed per group. (b) Representative topographical confocal scanning laser ophthalmoscopy (cSLO) 488 nm-fluorescence images showing the range of fluorescence intensities that was found in the different groups.CC BY · PubMed Central
Figure 2 Green fluorescent protein (GFP) fluorescence patterns of different recombinant AAV serotypes in wild type C57BL/6 mice following subretinal injection. The main images A–E are confocal stacks illustrating overall GFP expression patterns. Figure A illustrates transduction of the retinal pigment epithelium with rAAV2/2, whereas figure B demonstrates cone transduction. The boxed regions in images B–E are enlarged and shown as confocal slices in panels i-iii below for each serotype. GFP signal (green) and nuclear labeling with DAPI (blue) overlaid with immunostaining using cone arrestin (red) illustrate cone transduction using the different recombinant AAV serotypes. GCL = ganglion cell layer, INL = inner nuclear layer, ONL = outer nuclear layer, RPE = retinal pigment epithelium. Scale bar 50 µm.
Figure 2 Green fluorescent protein (GFP) fluorescence patterns of different recombinant AAV serotypes in wild type C57BL/6 mice following subretinal injection. The main images A–E are confocal stacks illustrating overall GFP expression patterns. Figure A illustrates transduction of the retinal pigment epithelium with rAAV2/2, whereas figure B demonstrates cone transduction. The boxed regions in images B–E are enlarged and shown as confocal slices in panels i-iii below for each serotype. GFP signal (green) and nuclear labeling with DAPI (blue) overlaid with immunostaining using cone arrestin (red) illustrate cone transduction using the different recombinant AAV serotypes. GCL = ganglion cell layer, INL = inner nuclear layer, ONL = outer nuclear layer, RPE = retinal pigment epithelium. Scale bar 50 µm.CC BY · PubMed Central
Figure 3 Green fluorescent protein (GFP) fluorescence patterns of different recombinant AAV serotypes in the degenerate retina of Pde6brd1/rd1 mice following subretinal injection. The main images a–d are confocal stacks illustrating overall GFP expression patterns. For each serotype, images i–iii are confocal slices showing GFP expression (green), nuclear labeling (blue) and immunostaining with calbindin identifying horizontal cells (red). Colocalisation of signals indicates horizontal cell transduction. Images iv–vi show colocalisation of GFP (green) in ganglion cells identified by Brn-3a immunostaining (red) demonstrating ganglion cell transduction. GCL = ganglion cell layer, INL = inner nuclear layer, RPE = retinal pigment epithelium. Scale bar: 30 µm for images a–d, 10 µm for images i–vi.
Figure 3 Green fluorescent protein (GFP) fluorescence patterns of different recombinant AAV serotypes in the degenerate retina of Pde6brd1/rd1 mice following subretinal injection. The main images a–d are confocal stacks illustrating overall GFP expression patterns. For each serotype, images i–iii are confocal slices showing GFP expression (green), nuclear labeling (blue) and immunostaining with calbindin identifying horizontal cells (red). Colocalisation of signals indicates horizontal cell transduction. Images iv–vi show colocalisation of GFP (green) in ganglion cells identified by Brn-3a immunostaining (red) demonstrating ganglion cell transduction. GCL = ganglion cell layer, INL = inner nuclear layer, RPE = retinal pigment epithelium. Scale bar: 30 µm for images a–d, 10 µm for images i–vi.CC BY · PubMed Central
Figure 4 Quantitative analysis of green fluorescent protein (GFP) fluorescence intensity on histological sections in eyes that underwent subretinal injection of different recombinant AAV serotypes expressing GFP (mean±SEM). Two mouse models for retinal degeneration (Abca4−/− and Pde6brd1/rd1 mice) are compared with wild type (WT) mice. Grey level analysis (upper row) represented an estimate for the level of transgene expression within transduced cells, whereas the percentage (%) of pixels above threshold (bottom row) represented an estimate of viral efficacy for cell transduction. 4 to 8 eyes were analysed per group. ONL = outer nuclear layer, RPE = retinal pigment epithelium.
Figure 4 Quantitative analysis of green fluorescent protein (GFP) fluorescence intensity on histological sections in eyes that underwent subretinal injection of different recombinant AAV serotypes expressing GFP (mean±SEM). Two mouse models for retinal degeneration (Abca4−/− and Pde6brd1/rd1 mice) are compared with wild type (WT) mice. Grey level analysis (upper row) represented an estimate for the level of transgene expression within transduced cells, whereas the percentage (%) of pixels above threshold (bottom row) represented an estimate of viral efficacy for cell transduction. 4 to 8 eyes were analysed per group. ONL = outer nuclear layer, RPE = retinal pigment epithelium.CC BY · PubMed Central
Figure 5 Green fluorescent protein (GFP) fluorescence following ex vivo administration of hybrid recombinant AAV vectors. GFP expression in macaque explants following rAAV2/Rec2 transduction (A) and histology of cross-sectional specimens showing expression of GFP (green) in the ganglion cell layer (B,C). Image D shows GFP expression in macaque explants following rAAV2/Rec3 transduction. GCL = ganglion cell layer; INL = inner nuclear layer.
Figure 5 Green fluorescent protein (GFP) fluorescence following ex vivo administration of hybrid recombinant AAV vectors. GFP expression in macaque explants following rAAV2/Rec2 transduction (A) and histology of cross-sectional specimens showing expression of GFP (green) in the ganglion cell layer (B,C). Image D shows GFP expression in macaque explants following rAAV2/Rec3 transduction. GCL = ganglion cell layer; INL = inner nuclear layer.CC BY · PubMed Central
Figure 6 Analysis of Green fluorescent protein (GFP) fluorescence intensity measurement of SH-SY5Y cells in vitro 9 days after transfection using different recombinant AAV serotypes. Representative images are shown of GFP fluorescence following transduction with rAAV2/2, rAAV2/5, rAAV2/Rec2 and rAAV2/Rec3 (A). Analysis of grey value (B) and percentage of pixels above threshold (C) are shown in the bottom row, demonstrating significant differences between standard rAAV2/2 and rAAV2/5 serotypes and hybrid recombinant vectors (*p<0.05, **p<0.01, ***p<0.001). In order to ensure levels of cell confluence did not differ between groups and affect transduction, Hoechst-labeled nuclei were counted in each field analyzed, with no significant difference between groups (D). Scale bar 50 µm.
Figure 6 Analysis of Green fluorescent protein (GFP) fluorescence intensity measurement of SH-SY5Y cells in vitro 9 days after transfection using different recombinant AAV serotypes. Representative images are shown of GFP fluorescence following transduction with rAAV2/2, rAAV2/5, rAAV2/Rec2 and rAAV2/Rec3 (A). Analysis of grey value (B) and percentage of pixels above threshold (C) are shown in the bottom row, demonstrating significant differences between standard rAAV2/2 and rAAV2/5 serotypes and hybrid recombinant vectors (*p<0.05, **p<0.01, ***p<0.001). In order to ensure levels of cell confluence did not differ between groups and affect transduction, Hoechst-labeled nuclei were counted in each field analyzed, with no significant difference between groups (D). Scale bar 50 µm.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 54

Metadata

Authors
Charbel Issa, P., De Silva, S. R., Lipinski, D. M., Singh, M. S., Mouravlev, A., You, Q., Barnard, A. R., Hankins, M. W., During, M. J., & MacLaren, R. E.
Affiliations
  • University of Oxford (GB)
  • University of Auckland (NZ)
  • National Institute for Health and Care Research (GB)
Corresponding author
MacLaren, Robert E.
Venue
PLoS ONE
Published
2013-04-09
Volume
8
Issue
4
Pages
e60361
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2052424035
Cited by
53
References
29
Citations by year
2026: 2 · 2025: 7 · 2024: 4 · 2023: 4 · 2022: 6 · 2021: 6 · 2020: 6 · 2019: 2 · 2018: 2 · 2017: 6 · 2016: 3 · 2015: 3 · 2014: 1
FWCI
1.55
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • ResearchSpace (University of Auckland) (submittedVersion, cc-by)
Funders
  • Wellcome Trust (086868, 094448/Z/10/Z, 094448, 086868/Z/08/Z)
  • National Institute for Health and Care Research
  • Royal College of Surgeons of Edinburgh
  • European Commission (237238)
  • National Institute of Neurological Disorders and Stroke (R01NS044576)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords
adeno-associated virus vectors, AAV2, retinal gene therapy, retinal degeneration, Stargardt disease, transduction efficiency, primate retina, T cell response, SH-SY5Y cells
MeSH terms
Dependovirus, Animals, Cell Line, Genetic Vectors, Humans, Mice, Transgenic, Primates, Recombination, Genetic, Retina, Retinal Degeneration, Transduction, Genetic, Gene Expression, Gene Transfer Techniques, Green Fluorescent Proteins, Mice, Viral Tropism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Assessment of Tropism and Effectiveness of New Primate-Derived Hybrid Recombinant AAV Serotypes in the Mouse and Primate Retina. https://app.cochat.ai/papers/10.1371/journal.pone.0060361
The paper
Charbel Issa, P., De Silva, S. R., Lipinski, D. M., Singh, M. S., Mouravlev, A., You, Q., Barnard, A. R., Hankins, M. W., During, M. J., & MacLaren, R. E. (2013). Assessment of Tropism and Effectiveness of New Primate-Derived Hybrid Recombinant AAV Serotypes in the Mouse and Primate Retina. PLoS ONE. https://doi.org/10.1371/journal.pone.0060361

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.